Stay updated on Asciminib Combo with Imatinib in CML-CP Clinical Trial
Sign up to get notified when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.

Latest updates to the Asciminib Combo with Imatinib in CML-CP Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedMinor editorial notes were added to clarify that publications are automatically filled from PubMed and that the revision was updated to v3.3.2; the older PubMed note and revision v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded 'Last Update Posted (Estimated)' timestamp to the Study Details page and removed the government funding status notice that previously appeared.SummaryDifference0.3%

- Check35 days agoChange DetectedExplicitly added secondary outcome definitions for MR^4.5, including best observed MR^4.5 rate up to 48 weeks, MR^4.5 rate at 96 weeks, and best observed MR^4.5 rate up to 96 weeks, and added a 'Last Update Posted' timestamp.SummaryDifference0.3%

- Check42 days agoChange Detected- The page now includes results-related information (Results First Posted date) and an updated Study Completion date, reflecting the current timeline for the trial and availability of results.SummaryDifference0.3%

- Check70 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdate standardizes capitalization of the medical term and its marker and increments the version from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to Asciminib Combo with Imatinib in CML-CP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.